Dengue Study | Success Story
According to the World Health Organization (WHO), “Dengue is transmitted by the bite of an Aedes mosquito infected with any one of the four dengue viruses. It occurs in tropical and sub-tropical areas of the world. Symptoms appear 3—14 days after the infective bite. Dengue fever is a febrile illness that affects infants, young children and adults. Symptoms range from a mild fever, to incapacitating high fever, with severe headache, pain behind the eyes, muscle and joint pain, and rash. Dengue haemorrhagic fever (fever, abdominal pain, vomiting, bleeding) is a potentially lethal complication, affecting mainly children.” The Pan American Health and Education Foundation (PAHEF) commissioned a study on dengue as part of a regional initiative to develop sound methodologies and approaches for estimating the socio-economic costs of dengue in the Americas. This document is meant to provide guidance for developing studies on estimating socioeconomic costs of dengue. It is hoped that these guidelines will be helpful to all countries in the Americas. When undertaking costing studies, guideline users are strongly advised to focus on a particular setting. Similarly, local dengue surveillance data in the country should be available. PAHEF thanks the International Vaccine Access Center (IVAC) at Johns Hopkins University (JHU) Bloomberg School of Public Health for their work on this study. |
|